Eu Ivdd Eu Ivd Self Testing On The Market ๐Ÿ‡น๐Ÿ‡ผ Taiwan

THE EDGE

Apex Biotechnology Corp. ยท ๐Ÿ‡น๐Ÿ‡ผ Taiwan
Devices (same UDI-DI)
1
Certificates
1
Countries
6
Notified Bodies
1

Basic Information

Primary DI
D-47136487610A05K
Basic UDI-DI Code
B-47136487610A05K
Reference
S54108, S54153, S54154, S54155, S54156, S54157, S54158
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd Self Testing
Status
On The Market

Additional Description

THE EDGE Blood Lactate Monitoring System provides you with important information concerning individual metabolism and oxygen debt. The system is especially designed for applications in a number of disorders including: liver disease, heart disease, diabetes mellitus, muscular dystrophy, thiamine deficiency, neoplastic disorders. Moreover, it can also be implemented in the field of medical diagnostics by specialists. Due to its reliable and accurate result evaluation (in-vitro), it is suitable for use in the support of the decision for further medical treatment of the patient. THE EDGE Blood Lactate Monitoring System is designed for both personal use and professional use.

CND Nomenclature Codes

Code Description
W010106010801 BLOOD TEST STRIPS CONTROLS
W0201069099 VARIOUS RAPID TEST CHEMISTRY / IMMUNOCHEMISTRY INSTRUMENTS - OTHER
W0101060104 LACTATE TEST STRIPS

Certificates

Type Number
IVDD Annex IV (excluding sections 4, 6) HL2100077-1

Available In Countries

๐Ÿ‡ง๐Ÿ‡ช Belgium ๐Ÿ‡ซ๐Ÿ‡ฎ Finland ๐Ÿ‡ต๐Ÿ‡ฑ Poland ๐Ÿ‡ต๐Ÿ‡น Portugal ๐Ÿ‡ธ๐Ÿ‡ช Sweden ๐Ÿ‡ธ๐Ÿ‡ฎ Slovenia

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Self Testing) and regulation (EU IVDD).

View all